Efficiency of the Crile Procedure in the Removal of Thyroid Malignancies Invaded into the Internal Jugular Vein
DOI:
https://doi.org/10.6000/1929-6029.2023.12.21Keywords:
Malignant tumours, thyroid gland, invasion, internal jugular vein, vein thrombosis, treatment prognosisAbstract
Aim: This work aims to determine the effectiveness of the Crile procedure for optimizing the diagnosis and treatment of patients with locally advanced thyroid malignancies.
Objects: The objects of the study were the results of treatment of patients with thyroid cancer using two techniques: Crile procedure and vein resection with sealing and preservation of blood flow.
Materials and Methods: The research was carried out experimentally using Crile surgical intervention and vein resection with sealing and preservation of blood flow. The effectiveness of the treatment was assessed by observing the recurrence and mortality rates. The patient’s quality of life was assessed through the conversation and questionnaire survey.
Results and Findings: It was found that Doppler ultrasonography of the main vessels in the neck helps to establish the internal jugular vein invasion, as well as its tumour thrombosis at the preoperative stage in clinical cases of suspected extrathyroidal extension of thyroid tumours in addition to radiological methods. A thyroid gland with a tumour invaded into the internal jugular vein must be radically removed with simultaneous resection of the affected part of the vein. We proved that the Crile procedure — resection of a vein with sealing of stumps and interruption of blood flow on one side of the neck — is a safe technique. It reduces the trauma and duration of the operation and reduces the likelihood of recurrence as it does not require further plastic surgery or vascular shunting with the restoration of blood flow. At the same time, bilateral interruption of blood flow in cases of resection of both internal jugular veins can lead to serious complications and requires a blood flow restoration operation from the side of the smaller tumour invasion.
References
Sydorenko OM, Sydorenko MO, Tymoshev МР. The epidemiology of thyroid cancer in the twentieth and early twenty-first century in Ukraine and Zaporizhzhia region. Current Issues in Pharmacy and Medicine: Science and Practice 2018; 11(3(28)): 322-325. https://doi.org/10.14739/2409-2932.2018.3.144485 DOI: https://doi.org/10.14739/2409-2932.2018.3.144485
Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, Vaccarella S. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol 2022; 10(4): 264-272. https://doi.org/10.1016/S2213-8587(22)00035-3 DOI: https://doi.org/10.1016/S2213-8587(22)00035-3
Song JL, Li LR, Xu ZL, Li JJ, Sun SR, Chen C. Long-Term Survival in Patients With Papillary Thyroid Cancer Who Did Not Undergo Prophylactic Central Lymph Node Dissection: A SEER-Based Study. World J Oncol 2022; 13(3): 136-144. https://doi.org/10.14740/wjon1483 DOI: https://doi.org/10.14740/wjon1483
Xu B, Ghossein R. Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management. Eur J Surg Oncol 2018; 44(3): 338-347. https://doi.org/10.1016/j.ejso.2017.05.002 DOI: https://doi.org/10.1016/j.ejso.2017.05.002
Myshunina TM, Guda BB, Bolgov MYu, Kalinichenko OV. TSH and thyroid cancer (literature analysis and results of own research). Clinical and Preventive Medicine 2019; 2(8): 97-111. https://doi.org/10.31612/2616-4868.2(8).2019.11 DOI: https://doi.org/10.31612/2616-4868.2(8).2019.11
Lloyd RV, Osamura RY, Kloppel G, Rosai J. WHO Classifcation of Tumors: Pathology and Genetics of Tumors of Endocrine Organs. 4th ed. Lyon, France: IARC Press; 2017; pp. 66-143.
Metere A, Aceti V, Giacomelli L. The surgical management of locally advanced well-differentiated thyroid carcinoma: changes over the years according to the AJCC 8th edition Cancer Staging Manual. Thyroid Res 2019; 12: 10-17. https://doi.org/10.1186/s13044-019-0071-3 DOI: https://doi.org/10.1186/s13044-019-0071-3
Chmielik E, Rusinek D, Oczko-Wojciechowska M, Jarzab M, Krajewska J, Czarniecka A, Jarzab B. Heterogeneity of Thyroid Cancer. Pathobiology 2018; 85(1-2): 117-129. https://doi.org/10.1159/000486422 DOI: https://doi.org/10.1159/000486422
Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA 2017; 317(13): 1338-1348. https://doi.org/10.1001/jama.2017.2719 DOI: https://doi.org/10.1001/jama.2017.2719
Parad MT, Fararouei M, Mirahmadizadeh AR, Afrashteh S. Thyroid cancer and its associated factors: A population-ba-sed case-control study. Int J Cancer 2021; 149(3): 514-521. https://doi.org/10.1002/ijc.33537 DOI: https://doi.org/10.1002/ijc.33537
Horgan D, Führer-Sakel D, Soares P, Alvarez CV, Fugazzola L, Netea-Maier RT, Jarzab B, Kozaric M, Bartes B, Schuster-Bruce J, Dal Maso L, Schlumberger M, Pacini F. Tackling Thyroid Cancer in Europe-The Challenges and Opportunities. Healthcare (Basel) 2022; 10(9): 1621. https://doi.org/10.3390/healthcare10091621 DOI: https://doi.org/10.3390/healthcare10091621
Houten R, Fleeman N, Kotas E, Boland A, Lambe T, Duarte R. A systematic review of health state utility values for thyroid cancer. Qual Life Res 2021; 30(3): 675-702. https://doi.org/10.1007/s11136-020-02676-2 DOI: https://doi.org/10.1007/s11136-020-02676-2
Nabhan F, Dedhia PH, Ringel MD. Thyroid cancer, recent advances in diagnosis and therapy. Int J Cancer 2021; 149(5): 984-992. https://doi.org/10.1002/ijc.33690 DOI: https://doi.org/10.1002/ijc.33690
Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M. Update on Fundamental Mechanisms of Thyroid Cancer. Front Endocrinol (Lausanne) 2020; 11: 102. https://doi.org/10.3389/fendo.2020.00102 DOI: https://doi.org/10.3389/fendo.2020.00102
Turk AT, Asa SL, Baloch ZW, Faquin WC, Fellegara G, Ghossein RA, Giordano TJ, LiVolsi VA, Lloyd R, Mete O, Rosai J, Suster S, Thompson LDR, Wenig BM. Interobserver Variability in the Histopathologic Assessment of Extrathyroidal Extension of Well Differentiated Thyroid Carcinoma Supports the New American Joint Committee on Cancer Eighth Edition Criteria for Tumor Staging. Thyroid 2019; 29(5): 619-624. https://doi.org/10.1089/thy.2018.0286 DOI: https://doi.org/10.1089/thy.2018.0286
Abboud B, Zeid HA, Rohbane R, Jabbour H, Baradhi A. Surgical management and prognosis of thyroid carcinomas invading adjacent structures. Otorhinolaryngol Head Neck Surg 2016; 1(5): 101-105. https://doi.org/10.15761/OHNS.1000125 DOI: https://doi.org/10.15761/OHNS.1000125
Dikici AS, Yıldırım O, Er ME, Kılıç F, Tutar O, Kantarcı F, Mihmanlı I. A rare complication of the thyroid malignancies: jugular vein invasion. Pol J Radiol 2015; 80: 360-63. https://doi.org/10.12659/PJR.894057 DOI: https://doi.org/10.12659/PJR.894057
Al-Jarrah Q, Abou-Foul A, Heis H. Intravascular extension of papillary thyroid carcinoma to the internal jugular vein: A case report. Int J Surg Case Rep 2014; 5(8): 551-553. https://doi.org/10.1016/j.ijscr.2014.06.005 DOI: https://doi.org/10.1016/j.ijscr.2014.06.005
Marcy PY, Thariat J, Chevenet C, Lacout A. Jugular Vein Invasion Diagnosis and Prognosis in Thyroid Carcinomas. Pol J Radiol 2016; 81: 268-269. https://doi.org/10.12659/PJR.896757 DOI: https://doi.org/10.12659/PJR.896757
Ho AL, Dedecjus M, Wirth LJ, Tuttle RM, Inabnet WB 3rd, Tennvall J, Vaisman F, Bastholt L, Gianoukakis AG, Rodien P, Paschke R, Elisei R, Viola D, So K, Carroll D, Hovey T, Thakre B, Fagin JA, ASTRA investigator group. Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA). J Clin Oncol 2022; 40(17): 1870-1878. https://doi.org/10.1200/JCO.21.00714 DOI: https://doi.org/10.1200/JCO.21.00714
Kamizono K, Ejima M, Taura M, Masuda M. Internal jugular vein reconstruction: application of conventional type A and novel type K methods. J Laryngol Otol 2011; 125: 643-648. https://doi.org/10.1017/S0022215110003038 DOI: https://doi.org/10.1017/S0022215110003038
Reiter M, Baumeister P. Venous anastomosis in free flap reconstruction after radical neck dissection: is the external jugular vein a feasible option? Eur Arch Otorhinolaryngol 2017; 274(5): 2239-2244. https://doi.org/10.1007/s00405-016-4443-1 DOI: https://doi.org/10.1007/s00405-016-4443-1
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
